The success of Viagra initially fueled a surge for pharma, but recent shifts present a uncertain picture for shareholders. Generic alternatives are eating into revenue, and persistent patent challenges add more risk to https://joycetvco262369.actoblog.com/42085309/sildenafil-and-the-pharmaceutical-industry-a-precarious-bet